Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$89.75 n/a | n/a%
04/24/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 64.54M 48.97M 31.39M 30.04M
Cost of Sales 2.56M 2.65M 874.00K 3.82M
Gross Operating Profit 61.98M 46.32M 30.51M 26.22M
Selling, General, and Administrative Expenses 22.57M 18.54M 16.11M 14.98M
Research & Development 12.12M 9.27M 10.79M 10.29M
Operating Income before D & A (EBITDA) 27.28M 18.50M 3.62M 948.00K
Depreciation & Amortization 6.57M 3.08M 2.73M 1.09M
Interest Income 0.00 0.00 0.00 31.00K
Other Income - Net -4.55M -3.66M -1.13M 1.92M
Special Income / Charges 0.00 -480.00K -315.00K -2.26M
Total Income Before Interest Expenses (EBIT) 16.16M 11.28M -560.00K -444.00K
Interest Expense 4.86M 2.08M 3.30M 2.51M
Pre-Tax Income 11.30M 9.21M -3.86M -2.95M
Income Taxes 410.00K 374.00K -1.19M -13.12M
Minority Interest -1.13M 0.00 0.00 0.00
Net Income From Continuing Operations 10.89M 8.83M -2.67M 10.17M
Net Income From Discontinued Operations 0.00 2.59M 2.15M 3.00K
Net Income From Total Operations 10.89M 11.42M -527.00K 10.18M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 12.02M 11.42M -527.00K 10.18M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
10.89M 9.31M -2.36M 12.43M
Preferred Dividends
Net Income Available To Common 10.89M 8.83M -2.67M 10.17M
Basic EPS from Continuing Ops. 0.59 0.43 -0.13 0.52
Basic EPS from Discontinued Ops. 0.00 0.13 0.11 0.00
Basic EPS from Total Operations 0.59 0.56 -0.02 0.52
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 -0.01 0.00
Basic EPS, Total 0.59 0.56 -0.03 0.52
Basic Normalized Net Income/Share 0.59 0.45 -0.11 0.64
EPS fr Continuing Ops. 0.56 0.43 -0.13 0.52
EPS fr Discontinued Ops 0.00 0.12 0.11 0.00
EPS fr Total Ops. 0.56 0.55 -0.02 0.52
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 -0.01 0.00
EPS, Total 0.56 0.55 -0.03 0.52
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.56 0.45 -0.12 0.63
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter